RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 79.35
-1.35 (-1.67%)
Sep 1, 2026, 4:08 PM HKT
RemeGen Employees
RemeGen had 3,145 employees as of June 30, 2026.
Employees
3,145
Change
n/a
Growth
n/a
Revenue / Employee
2.94M HKD
Profits / Employee
2.14M HKD
Market Cap
65.83B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 3,145 | - | - |
| Dec 31, 2025 | 3,048 | 49 | 1.63% |
| Dec 31, 2024 | 2,999 | -616 | -17.04% |
| Dec 31, 2023 | 3,615 | 283 | 8.49% |
| Dec 31, 2022 | 3,332 | 1,211 | 57.10% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 22,838 |
| Innovent Biologics | 8,754 |
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Akeso | 4,082 |
| Shanghai Henlius Biotech | 4,082 |
| Shanghai Junshi Biosciences | 3,055 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,300 |
RemeGen News
- 8 days ago - RemeGen Earnings release: Q2 2026 - Filings
- 4 months ago - RemeGen Earnings release: Q1 2026 - Filings
- 5 months ago - RemeGen Annual report: Q4 2025 - Filings
- 5 months ago - RemeGen Slides: Q4 2025 - Filings
- 5 months ago - RemeGen Earnings release: Q4 2025 - Filings
- 8 months ago - AbbVie, RemeGen partner on experimental solid tumor treatment - Reuters
- 10 months ago - RemeGen Earnings release: Q3 2025 - Filings
- 10 months ago - RemeGen Slides: Q3 2025 - Filings